VEGFA and neoplasm: This trial also investigated potential correlations between clinical outcome and other soluble proteins that are directly related to the mechanism of action of sunitinib and are associated with angiogenesis or tumor proliferation (VEGF-A, sVEGFR-2, sVEGFR-3, and sKIT).